We are monitoring the impact of COVID-19 on Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2821
Share on
Share on

Global Sepsis Diagnostics Market Size, Share, Trends, COVID-19 impact and Growth Analysis Report – Segmented By Pathogen, Product, Technology, Method, Usability and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2821
Pages: 175

Sepsis Diagnostics Market Size (2021 to 2026)

As per our research report, the global sepsis diagnostics market size was worth USD 1014 million in 2021 and is estimated to be growing at a CAGR of 8.51% to reach USD 1525 million by 2026. The increasing prevalence of the disease and its fatal effects have stimulated its growth.

Sepsis is defined as the body’s reaction to the bacteria, fungal, viral, or plastic infection, leading to the systemic inflammatory response, organ failure, or organ dysfunction.  Sepsis is emerging as a leading cause of mortality around the globe. The market players are focussing on launching advanced technological products to ensure sepsis diagnosis at the initial stages. Moreover, companies enter mergers and acquisitions to operate research and development activities and expand nationwide market growth.

As per the reports, some products have already been introduced in the United States in food and drug administration for diagnosis purposes. According to the Centers for disease control and prevention, it is estimated that 1.7 million people suffer from hospital-acquired infections (HAI) every year in the United States. As per the ECDC, 2013, around 4.1 million patients were diagnosed with HAI in Europe. However, developed countries equipped with advanced facilities and fewer sepsis cases have been recorded in the study of more than 7000 patient outcomes using the Early Sense systems. The number of ICU days for transferred cases has decreased by 46%. 

MARKET DRIVERS:

The growth of the global sepsis diagnostic market is anticipated to be driven by factors such as the growing burden of infectious diseases and an increasing number of sepsis incidences globally. According to thelancet.com, An estimated 48.9 million sepsis cases were identified in 2017, in which 11.0 sepsis-related deaths were recorded. People with weak immune systems and people with chronic diseases such as diabetes, cancer, and AIDS are vulnerable to contracting sepsis, which is expected to drive market growth.

However, the increasing prevalence of antibiotic-resistant bacterial strains and rising concern about the health of the people worldwide, and growing healthcare expenditure is projected to improve the market growth. Majorly, government incentives and investment expenditure to improve the healthcare expenditure propel the Sepsis Diagnostics Market during the forecast period.

MARKET RESTRAINTS:

However, lack of standard protocol for sepsis and unavailability of professionals in developing countries are major challenging factors for the global sepsis diagnostics market growth.

Impact of COVID-19 on the global sepsis diagnostics market:

The outbreak of COVID-19 has increased the overall risk of sepsis among the population. As per the global alliance, it is stated that COVID-19 can cause sepsis. The COVID-19 infected patient's body gets overwhelmed, and a life-threatening response can lead to organ damage and lead to death. As per reports, one in three COVID-19 patients dies in the hospital because of sepsis in the United States. With the high vulnerability of the disease in this region, the market is projected to have better growth in the coming years.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Pathogen, Product, Technology, Method, Usability, End-User, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the global sepsis diagnostics market has been segmented and sub-segmented based on the pathogen, product, technology, method, usability, end-user, and region.

Sepsis Diagnostics Market Analysis – By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections    

Based on the pathogen, the bacterial sepsis segment is forecasted to register the leading market share during the forecast period in the global sepsis diagnostics market. Based on the fact that most patients suffering from blood poisoning disease are patients of bacterial infection, the bacterial sepsis segment held the most significant share in 2019. Gram-negative bacteria are the most frequent bacterial sepsis. The gram-positive bacterial sepsis segment is anticipated to dominate the market during the forecast period. Extensive research and development activities and favorable regulatory approval of novel solutions are expected to support the segment growth.

Due to the rise of Candida infection resulting in septic poisoning, fungal sepsis is to expand at an appealing CAGR. This disease comes from a smaller number of viruses and parasites, so this segment accounted for a minimal share in 2020.         

Sepsis Diagnostics Market Analysis – By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software   

Based on product, Blood culture media was estimated to be the largest grossing segment in 2020. It grows more rapidly over the forecast period because physicians know blood culture as the gold standard form and cost-effective method of screening. The blood culture media is considered as the cost-effective and standard method by most clinicians.

The assay kits and reagents segment will show lucrative growth due to their new diagnostic capability and the implementation of automated testing by significant companies.

Sepsis Diagnostics Market Analysis – By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays     
  • Flow Cytometry   
  • Other Technologies      

Sepsis Diagnostics Market Analysis – By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

Sepsis Diagnostics Market Analysis – By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing     

Sepsis Diagnostics Market Analysis – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the North American sepsis diagnostics market recorded the largest share in terms of revenue in the global market in 2019, and it is expected to increase its dominance during the forecast period. With an increase in healthcare expenditure, rapid adoption of advanced diagnostic products in the United States is expected to drive this regional market. Favorable reimbursement scenarios for diagnostic tests in the United States and active participation of key market players are projected to grow.

The European sepsis diagnostics market is projected to grow at a significant rate between 2020 to 2025. The European market held the second-largest share concerning revenue in the global market in 2019. High incidence of healthcare expenditure and advanced medical procedures are augmenting market growth over the years. 

The Asia Pacific sepsis diagnostics market is the quickest growing region globally and is predicted to grow at a healthy rate between 2020 to 2025. Improving healthcare infrastructure facilities and the availability of advanced diagnostic products and favorable government initiatives, and the rise in healthcare expenditure influence market growth in this region.

The sepsis diagnostics market in the Middle East & Africa region was accounted for a small share in the global market in 2019 due to the growing burden of infectious diseases. It is further projected to grow at a steady rate from 2020 to 2025. The increasing number of sepsis incidences in this region and raising awareness among healthcare people augment market growth.

KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:

Some of the notable companies dominating the global sepsis diagnostics market profiled in this report are BioMérieux SA, T2 Biosystems Inc., Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc., Abbott Laboratories, Roche Diagnostics Limited, Becton Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

In April 2018, Curetis NV collaborated with partner Acumen Research Laboratories Pte. Ltd received approval for Unyvero BCU Cartridge for bloodstream infections in Singapore.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  3. Global Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  7. Global Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Software Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  12. Global Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  17. Global Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  18. Global Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  20. Global Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  23. North America Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  27. North America Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Software Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  32. North America Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  37. North America Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  38. North America Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  40. North America Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  41. North America Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  42. United States Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  43. United States Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  44. United States Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  45. United States Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  46. United States Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  47. Canada Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  48. Canada Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  49. Canada Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  50. Canada Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  51. Canada Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  52. Europe Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  53. Europe Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  54. Europe Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  56. Europe Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  57. Europe Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  60. Europe Software Market, By Region, From 2021 to 2026 (USD Billion)
  61. Europe Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  62. Europe Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  64. Europe Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  65. Europe Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  66. Europe Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  67. Europe Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  68. Europe Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  69. Europe Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  70. Europe Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  71. Europe Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  72. U.K. Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  73. U.K. Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  74. U.K. Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  75. U.K. Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  76. U.K. Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  77. Germany Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  78. Germany Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  79. Germany Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  80. Germany Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  81. Germany Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  82. France Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  83. France Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  84. France Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  85. France Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  86. France Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  87. Italy Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  88. Italy Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  89. Italy Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  90. Italy Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  91. Italy Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  92. Spain Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  93. Spain Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  94. Spain Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  95. Spain Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  96. Spain Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  97. Asia-Pacific Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  98. Asia-Pacific Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  99. Asia-Pacific Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  100. Asia-Pacific Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  101. Asia-Pacific Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  102. Asia-Pacific Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  103. Asia-Pacific Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  104. Asia-Pacific Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  105. Asia-Pacific Software Market, By Region, From 2021 to 2026 (USD Billion)
  106. Asia-Pacific Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  107. Asia-Pacific Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  108. Asia-Pacific Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  109. Asia-Pacific Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  110. Asia-Pacific Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  111. Asia-Pacific Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  112. Asia-Pacific Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  113. Asia-Pacific Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  114. Asia-Pacific Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  115. Asia-Pacific Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  116. Asia-Pacific Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  117. Japan Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  118. Japan Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  119. Japan Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  120. Japan Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  121. Japan Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  122. China Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  123. China Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  124. China Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  125. China Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  126. China Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  127. India Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  128. India Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  129. India Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  130. India Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  131. India Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  132. Australia Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  133. Australia Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  134. Australia Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  135. Australia Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  136. Australia Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  137. South Korea Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  138. South Korea Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  139. South Korea Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  140. South Korea Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  141. South Korea Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  142. Latin America Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  143. Latin America Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  144. Latin America Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  145. Latin America Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  146. Latin America Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  147. Latin America Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  148. Latin America Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  149. Latin America Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  150. Latin America Software Market, By Region, From 2021 to 2026 (USD Billion)
  151. Latin America Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  152. Latin America Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  153. Latin America Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  154. Latin America Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  155. Latin America Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  156. Latin America Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  157. Latin America Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  158. Latin America Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  159. Latin America Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  160. Latin America Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  161. Latin America Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  162. Brazil Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  163. Brazil Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  164. Brazil Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  165. Brazil Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  166. Brazil Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  167. Argentina Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  168. Argentina Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  169. Argentina Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  170. Argentina Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  171. Argentina Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  172. Mexico Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  173. Mexico Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  174. Mexico Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  175. Mexico Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  176. Mexico Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  177. Rest of Latin America Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  178. Rest of Latin America Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  179. Rest of Latin America Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  180. Rest of Latin America Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  181. Rest of Latin America Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  182. Middle East & Africa Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  183. Middle East & Africa Bacterial Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  184. Middle East & Africa Fungal Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  185. Middle East & Africa Other Pathogen Infections Market, By Region, From 2021 to 2026 (USD Billion)
  186. Middle East & Africa Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  187. Middle East & Africa Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  188. Middle East & Africa Blood Culture Media Market, By Region, From 2021 to 2026 (USD Billion)
  189. Middle East & Africa Assay Kits and Reagents Market, By Region, From 2021 to 2026 (USD Billion)
  190. Middle East & Africa Software Market, By Region, From 2021 to 2026 (USD Billion)
  191. Middle East & Africa Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  192. Middle East & Africa Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  193. Middle East & Africa Microbiology Market, By Region, From 2021 to 2026 (USD Billion)
  194. Middle East & Africa Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  195. Middle East & Africa Flow Cytometry Market, By Region, From 2021 to 2026 (USD Billion)
  196. Middle East & Africa Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  197. Middle East & Africa Conventional Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  198. Middle East & Africa Automated Sepsis Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  199. Middle East & Africa Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  200. Middle East & Africa Laboratory Testing Market, By Region, From 2021 to 2026 (USD Billion)
  201. Middle East & Africa Point-of-Care Testing Market, By Region, From 2021 to 2026 (USD Billion)
  202. Middle East Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  203. Middle East Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  204. Middle East Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  205. Middle East Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  206. Middle East Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)
  207. Africa Sepsis Diagnostics Market, By Pathogen, From 2021 to 2026 (USD Billion)
  208. Africa Sepsis Diagnostics Market, By Products, From 2021 to 2026 (USD Billion)
  209. Africa Sepsis Diagnostics Market, By Technology, From 2021 to 2026 (USD Billion)
  210. Africa Sepsis Diagnostics Market, By Method, From 2021 to 2026 (USD Billion)
  211. Africa Sepsis Diagnostics Market, By Usability, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample